| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| ¿µ¹® | sports medicine | ÇÑ±Û | ½ºÆ÷Ã÷ÀÇÇÐ |
|---|---|---|---|
| ¼³¸í | ½ºÆ÷Ã÷°¡ »ç¶÷ÀÇ ¸ö¿¡ ¹ÌÄ¡´Â »ý¸®Àû ¿µÇâ°ú °Ç° °ü¸®, ½Åü¹ß´Þ, °æ±â ´É·Â Çâ»ó¿¡ °üÇÏ¿© ¿¬±¸ÇÏ´Â Çй®. ÀÇÇÐÀÇ ÇÑ ºÐ¾ßÀÌ´Ù. ÇØºÎÇÐ-»ý¸®ÇÐ-»ýÈÇÐ µîÀÇ ±âÃÊ ºÐ¾ß¿Í ÀÓ»ó ºÐ¾ß¸¦ ¸Á¶óÇÑ ÀÇÇÐÀû Áö½ÄÀ» ¹ÙÅÁÀ¸·Î ÇÏ¿© ½ºÆ÷Ã÷¿Í ÀÎüÀÇ °ü°è¸¦ ¿¬±¸ÇÏ°í ¹Ý¿µ½ÃŲ´Ù. ½ºÆ÷Ã÷ÀÇÇÐÀº »ý¸®ÇÐÀû-ÇØºÎÇÐÀû-Á¤½Å°úÇÐÀû-»ýÈÇÐÀûÀÎ ¿îµ¿ÀÇ È¿°ú¸¦ Æò°¡ ºÐ¼®ÇÏ¿© À̸¦ Åä´ë·Î ÈÆ·Ã¹æ¹ýÀÇ °³¼±Á¡À» Ãß±¸ÇÏ°í ½ºÆ÷Ã÷ ¿Ü»óÀÇ ¿¹¹æ°ú Ä¡·áÁöħÀ» ¸¶·ÃÇÏ¿© ¼±¼öµéÀÇ ¿µ¾ç°ü¸®´Â ¹°·Ð ȯ°æº¯È¿¡ ´ëóÇÏ´Â ¹æ¾ÈÀ» ¸¶·ÃÇÏ´Â ÀÎü¿Í ½ºÆ÷Ã÷ Àü¹Ý¿¡ °üÇÑ Æø ³ÐÀº Çй®ÀÌ´Ù. |
||
| ¿µ¹® | preventive medicine | ÇÑ±Û | ¿¹¹æÀÇÇÐ |
|---|---|---|---|
| ¼³¸í | º´ÀÇ ¿¹¹æ¿¡ ÁßÁ¡À» µÐ À§»ýÇÐÀÇ ÇÑ ºÐ¾ß. º¸Åë Ä¡·áÀÇÇÐÀÇ ´ëÀÀ¾î·Î ¾²ÀδÙ. ÀÇÇÐÀº °Ç°À» À¯Áö-ÁõÁøÇϰí Áúº´À» ¿¹¹æÇÏ´Â °ÍÀ̸ç, º´ÀÌ ³µÀ» ¶§´Â °Ç°À» ȸº¹½Ã۰í ÀçȰ½ÃÄѼ »çȸ¿¡ ÀûÀÀÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â °ÍÀÌ´Ù. ÀϹÝÀûÀ¸·Î ÀÇÇÐÀ» ±âÃÊÀÇÇÐ-ÀÓ»óÀÇÇÐ-¿¹¹æÀÇÇÐÀ¸·Î Å©°Ô ³ª´©´Â ÀÔÀåµµ ÀÖ´Ù. Áúº´ÀÌ ¹ß»ýÇÏ´Â µ¥¿¡´Â ¼¼°¡Áö ¿äÀÎÀÌ ÀÖ´Ù. ù°´Â ¹°¸®Àû-»ý¹°ÇÐÀû-»çȸÀû -¹®ÈÀû-°æÁ¦Àû ȯ°æÀÌ´Ù. µÑ°´Â ¼÷ÁÖ(Àΰ£)À̸ç, ¿©±â¿¡´Â ¿¬·É-¼º-¿µ¾ç-»ýȰ½À°ü-ÀÇ·áÇüÅ µîÀÌ °ü·ÃµÈ´Ù. ¼Â°´Â º´¿øÃ¼·Î¼ ¼¼±Õ-¹°¸®Àû ¿äÀÎ ¹× ÈÇй°Áú µîÀ» µé¼ö ÀÖ´Ù. Àΰ£°ú º´¿øÃ¼´Â ȯ°æÀ» Áö·¿´ë·Î ÇÏ´Â °ü°è¸¦ °¡Áø´Ù. |
||
| ¿µ¹® | medicine | ÇÑ±Û | ÀÇÇÐ |
|---|---|---|---|
| ¼³¸í | Àΰ£À» Áúº´À¸·ÎºÎÅÍ ±¸ÇÏ°í °Ç°¹ýÀ» ¸ð»öÇÏ´Â Çй®. ÀÇÇÐÀº ÀηùÀÇ ¿ª»ç¿Í ´õºÒ¾î °æÇèÀÇ·á·Î¼ Á¸ÀçÇØ ¿ÔÀ¸¸ç, ÀϹݰúÇÐÀÌ Áøº¸ÇÔ¿¡ µû¶ó¼ µ¶ÀÚ¼ºÀ» Áö´Ñ °úÇÐÀ¸·Î ¹ßÀüÇÏ¿© ÀÎü¿¡ °üÇÑ ¿¬±¸¿Í Áúº´ÀÇ ¿¹¹æ ¹× Ä¡·á¸¦ ¿¬±¸ÇÏ´Â Çй®À̶ó°í Á¤ÀǵȴÙ. ÀÇÇÐÀº Áúº´¿¡ °üÇØ¼ ¿¬±¸Çϰí, ±× ¿¹¹æÀ̳ª Áø´Ü-Ä¡·á ¹× °Ç°ÀÇ À¯Áö¿Í ÁõÁøÀ» ¸ñÀûÀ¸·Î ÇÏ´Â Çй®ÀÌ´Ù. ¿ª»çÀûÀ¸·Î º´À» °íÄ¡´Â °Í, Áï ±â¼úÀû ¶Ç´Â ÀÀ¿ëÀû Ãø¸éÀ̶ó°í ÇÒ ¼ö ÀÖ´Â ÀÇ·á°¡ ¸ÕÀú ¹ß´ÞÇϰí Áß¿ä½ÃµÇ¾î ¿ÔÀ¸¸ç, ±×·± Á¡¿¡¼ ÀÓ»óÀÇÇÐÀÌ ¸ÕÀú ¹ß´ÞÇÏ¿´°í, ±âÃÊÀÇÇаú ¿¹¹æÀÇÇÐÀÌ ¹ßÀüÇÏ°Ô µÇ¾ú´Ù. ÀÇÇÐÀº ´Ü¼øÈ÷ ÀÀ¿ëÀû °úÇÐÀÌ ¾Æ´Ï°í, °¡Àå °íµîÇÑ »ý¹°·Î¼ÀÇ Àΰ£À» ´ë»óÀ¸·Î ÇÑ »ý¹°°úÇÐÀÌ¸ç »ý¸í°úÇÐÀÇ ¹ßÀü¿¡ Å©°Ô ±â¿©ÇÏ¿´°í, ¶Ç Çϰí ÀÖ´Ù. |
||
| ¿µ¹® | rehabilitation medicine | ÇÑ±Û | ÀçȰÀÇÇÐ |
|---|---|---|---|
| ¼³¸í | Àå¾ÖÀÚ¸¦ ½ÅüÀû-Á¤½ÅÀûÀ¸·Î °¡´ÉÇÑ ÃÖ´ëÇѵµ±îÁö Á¤»óÀûÀ¸·Î ȸº¹½Ã۱â À§ÇÑ Çй®. ÀÇÇÐÀÇ ÇÑ ºÐ¾ßÀÌ´Ù. |
||
| AM | Academic Medicine [journal]; actomyosin; acute myelofibrosis; adult male; adult monocyte; aerospace ... |
|---|---|
| NEJM | New England Journal of Medicine |
| NYHA | New York Heart Association Heart Disease¿¡ ´ëÇÑ Functional Classification &nbs... |
| NYC | New York City [medium] |
| NYHA | New York Heart Association |
| CAM | Complementary and Alternative Medicine |
|---|---|
| NEJM | New England Journal of Medicine |
| CAM | Complementary/alternative medicine |
| NY | New York |
| NYC | New York City |
| New York Heart Association classification | A functional classification to assess cardiovascular disability. Class I: patients with cardiac disease without limitation of physical activity. Ordinary activity does not cause symptoms. Class II: patients with cardiac disease with slight limitation of activity; comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea or angina. Class III: patients with cardiac disease producing marked limitation of activity: comfortable at rest. Less than ordinary physical activity causes symptoms. Class IV: patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms may be present even at rest. (05 Mar 2000) |
|---|---|
| alternative medicine | A catch-all phrase for a long list of treatments or medicinal systems including traditional systems such as Chinese or Ayurvedic medicine, homeopathy, various herbals and other miscellaneous treatments that have not been accepted by the mainstream, or Western, medical establishment. Alternative medicine is also referred to as complementary medicine (see). The designation alternative medicine is not equivalent to holistic medicine, which is a more narrow term. See: Holistic Medicine. (09 Oct 1997) |
| journal article | The predominant publication type for articles and other items indexed for nlm databases. (12 Dec 1998) |
| complementary medicine | A nonmainstream health care provided in addition or instead of standard medical practice. See: alternative medicine. (09 Oct 1997) |
| religion and medicine | The interrelationship of medicine and religion. (12 Dec 1998) |
| alternative | Available in place of something else. (18 Nov 1997) |
| alternative hypothesis | In Neyman-Pearson testing of a hypothesis, the hypothesis or family of hypotheses about the numerical value of a parameter if and only if the null hypothesis is rejected as untenable. (05 Mar 2000) |
| alternative inheritance | Galton's term for an assumed form in which all the characters are derived from one parent. (05 Mar 2000) |
| alternative mRNA splicing | Splicing different exons in or out of messenger RNA to form different mRNA transcripts. (09 Oct 1997) |
| alternative oxidase | <enzyme> The terminal oxidase in alternative pathway respiration, as seen in plants like sauromatum guttatum (voodoo lily); amino acid sequence for tobacco alternative oxidase (aox1) in first source Registry number: EC 1.- Synonym: aox1 gene product, aox2 gene product, aox3 gene product (26 Jun 1999) |
| alternative oxidase pathway | Pathway of mitochondrial electron transport in higher plants, particularly in fruits and seeds, that does not involve cytochrome oxidase and thus is resistant to cyanide. (18 Nov 1997) |
| alternative pathway | See: complement activation. (18 Nov 1997) |
| alternative splicing | A process whereby multiple protein isoforms are generated from a single gene. Alternative splicing involves the splicing together of nonconsecutive exons during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form messenger RNA. The alternative forms produce proteins in which one part is common while the other part is different. (12 Dec 1998) |
| alternative therapy | A term given to nonconventional therapy usually given by persons who do not have a medical qualification. (16 Dec 1997) |
| alternative tremor | A coarse, low frequency (3-8 Hz) pathologic tremor produced by alternating contraction of muscles and their antagonists; seen with Parkinson disease and kinetic predominant action tremor. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|